Bupropion Hydrochloride; Dextromethorphan Hydrobromide Patent Expiration
Bupropion Hydrochloride; Dextromethorphan Hydrobromide is Used for treating major depressive disorder by administering dextromethorphan and bupropion in combination. It was first introduced by Axsome Therapeutics Inc
Bupropion Hydrochloride; Dextromethorphan Hydrobromide Patents
Given below is the list of patents protecting Bupropion Hydrochloride; Dextromethorphan Hydrobromide, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Auvelity | US11844797 | Combination of dextromethorphan and bupropion for treating depression | Apr 20, 2043 | Axsome |
| Auvelity | US11839612 | Compounds and combinations thereof for treating neurological and psychiatric conditions | Mar 02, 2043 | Axsome |
| Auvelity | US11752144 | Compounds and combinations thereof for treating neurological and psychiatric conditions | Feb 23, 2043 | Axsome |
| Auvelity | US12042473 | Compounds and combinations thereof for treating neurological and psychiatric conditions | Feb 23, 2043 | Axsome |
| Auvelity | US12146889 | Fluorine-Containing Compound, Fluorine-Containing Polymer, Negative-Type Resist Composition, and Patterning Process Using Same | Feb 23, 2043 | Axsome |
| Auvelity | US11986444 | Treatment of poor metabolizers of dextromethorphan with a combination of bupropion and dextromethorphan | Feb 15, 2043 | Axsome |
| Auvelity | US12036191 | Treatment of poor metabolizers of dextromethorphan with a combination of bupropion and dextromethorphan | Feb 15, 2043 | Axsome |
| Auvelity | US11730706 | Treatment of depression in certain patient populations | Jan 23, 2043 | Axsome |
| Auvelity | US11883373 | Treatment of depression in certain patient populations | Jan 23, 2043 | Axsome |
| Auvelity | US11717518 | Bupropion dosage forms with reduced food and alcohol dosing effects | Jan 20, 2043 | Axsome |
| Auvelity | US11925636 | Bupropion dosage forms with reduced food and alcohol dosing effects | Jan 20, 2043 | Axsome |
| Auvelity | US12156914 | Pharmaceutical compositions comprising bupropion and cysteine | Jan 20, 2043 | Axsome |
| Auvelity | US11896563 | Bupropion and dextromethorphan for reduction of suicide risk in depression patients | Dec 01, 2041 | Axsome |
| Auvelity | US10780064 | Bupropion as a modulator of drug activity | Jan 07, 2040 | Axsome |
| Auvelity | US10925842 | Bupropion as a modulator of drug activity | Jan 07, 2040 | Axsome |
| Auvelity | US10940124 | Bupropion as a modulator of drug activity | Jan 07, 2040 | Axsome |
| Auvelity | US10966942 | Bupropion as a modulator of drug activity | Jan 07, 2040 | Axsome |
| Auvelity | US10780066 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects | Nov 09, 2034 | Axsome |
| Auvelity | US10058518 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US10064857 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US10080727 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects | Nov 05, 2034 | Axsome |
| Auvelity | US10092560 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects | Nov 05, 2034 | Axsome |
| Auvelity | US10092561 | Compositions and methods comprising bupropion or related compounds for sustained delivery of dextromethorphan | Nov 05, 2034 | Axsome |
| Auvelity | US10105327 | Compositions and methods for increasing the metabolic lifetime of dextromethorphane and related pharmacodynamic effects | Nov 05, 2034 | Axsome |
| Auvelity | US10105361 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects | Nov 05, 2034 | Axsome |
| Auvelity | US10251879 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US10463634 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects | Nov 05, 2034 | Axsome |
| Auvelity | US10512643 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects | Nov 05, 2034 | Axsome |
| Auvelity | US10548857 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects | Nov 05, 2034 | Axsome |
| Auvelity | US10596167 | Compositions and methods comprising bupropion or related compounds for sustained delivery of dextromethorphan | Nov 05, 2034 | Axsome |
| Auvelity | US10772850 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US10786469 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects | Nov 05, 2034 | Axsome |
| Auvelity | US10786496 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects | Nov 05, 2034 | Axsome |
| Auvelity | US10799497 | Combination of dextromethorphan and bupropion for treating depression | Nov 05, 2034 | Axsome |
| Auvelity | US10806710 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US10864209 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US10874663 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US10874664 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US10874665 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US10881624 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects | Nov 05, 2034 | Axsome |
| Auvelity | US10881657 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US10894046 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US10894047 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US10898453 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US10933034 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US10945973 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US10966941 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US10966974 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US11020389 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US11058648 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US11090300 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US11096937 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US11123343 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US11129826 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US11141388 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US11141416 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US11147808 | Method of decreasing the fluctuation index of dextromethorphan | Nov 05, 2034 | Axsome |
| Auvelity | US11185515 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US11191739 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US11197839 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US11207281 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US11213521 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US11229640 | Combination of dextromethorphan and bupropion for treating depression | Nov 05, 2034 | Axsome |
| Auvelity | US11234946 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US11253491 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US11253492 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US11273133 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US11273134 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US11285118 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US11285146 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US11291638 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US11291665 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US11298351 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US11298352 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US11311534 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US11344544 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US11357744 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US11364233 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US11382874 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US11419867 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US11426370 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US11426401 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US11433067 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US11439636 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US11478468 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US11497721 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US11510918 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US11517542 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US11517543 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US11524007 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US11524008 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US11534414 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US11541021 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US11541048 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US11596627 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US11617728 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US11617747 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US11779579 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US11969421 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US12109178 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US9168234 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US9198905 | Compositions and methods for reducing dextrorphan plasma levels and related pharmacodynamic effects | Nov 05, 2034 | Axsome |
| Auvelity | US9205083 | Compositions and methods comprising erythrohydroxybupropion and related compounds for improving the efficacy of dextromethorphan | Nov 05, 2034 | Axsome |
| Auvelity | US9238032 | Compositions and methods comprising bupropion or related compounds for sustained delivery of dextromethorphan | Nov 05, 2034 | Axsome |
| Auvelity | US9278095 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US9314462 | Compositions and methods for increasing dextromethorphan plasma levels and related pharmacodynamic effects | Nov 05, 2034 | Axsome |
| Auvelity | US9370513 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects | Nov 05, 2034 | Axsome |
| Auvelity | US9375429 | Compositions and methods comprising erythrohydroxybupropion and related compounds for improving the efficacy of dextromethorphan | Nov 05, 2034 | Axsome |
| Auvelity | US9408815 | Bupropion as a modulator of drug activity | Nov 05, 2034 | Axsome |
| Auvelity | US9421176 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects | Nov 05, 2034 | Axsome |
| Auvelity | US9457023 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects | Nov 05, 2034 | Axsome |
| Auvelity | US9457025 | Compositions and methods comprising bupropion or related compounds for sustained delivery of dextromethorphan | Nov 05, 2034 | Axsome |
| Auvelity | US9474731 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects | Nov 05, 2034 | Axsome |
| Auvelity | US9486450 | Hydroxybupropion and related compounds as modulators of drug plasma levels | Nov 05, 2034 | Axsome |
| Auvelity | US9700528 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects | Nov 05, 2034 | Axsome |
| Auvelity | US9700553 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects | Nov 05, 2034 | Axsome |
| Auvelity | US9707191 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects | Nov 05, 2034 | Axsome |
| Auvelity | US9763932 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects | Nov 05, 2034 | Axsome |
| Auvelity | US9861595 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects | Nov 05, 2034 | Axsome |
| Auvelity | US9867819 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects | Nov 05, 2034 | Axsome |
| Auvelity | US9968568 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects | Nov 05, 2034 | Axsome |
| Auvelity | US8569328 | Compositions and methods comprising tilidine or related compounds and dextromethorphan | Oct 29, 2033 | Axsome |
Bupropion Hydrochloride; Dextromethorphan Hydrobromide's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List